Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00186394
Status:
COMPLETED
Last Update Posted:
2010-07-27
First Post:
2005-09-13
Brief Title:
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkins Lymphoma
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkins Lymphoma
Status:
COMPLETED
Status Verified Date:
2010-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the role of allogeneic hematopoietic cell transplantation in the treatment of NHL
Detailed Description:
To determine safety and toxicity of a regimen of high dose chemotherapy with allogeneic peripheral blood progenitor cell transplantation determine the efficacy of the procedure by following clinical outcomes and quality of life measures and evaluate graft versus host disease incidence and severity with regimen
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCT00186394 | None | None | None |
| 76679 | None | None | None |
| BMT4L | None | None | None |